⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 4, 2024Open Access

Figure S1 from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo

Ian Nessler Baron Rubahamya Anna Kopp Scott Hofsess Thomas M. Cardillo Nalini Sathyanarayan Jennifer Donnell Serengulam V. Govindan Greg M. Thurber

View Full Paper

Ask AI

Bookmark

Share

Abstract

SE-HPLC Plot CEA-IgG. Size-exclusion HPLC (SE-HPLC) of CEA IgG, M85151a (XAb in our description), product #l0-C10C, from Fitzgerald Industries International. HPLC detection at 280 nm, the antibody absorbance region.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nessler et al. (2024) studied this question.

synapsesocial.com/papers/68e75dd0b6db6435876d4c2b https://doi.org/10.1158/1535-7163.25338073.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S3 from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>2024
2Figure S4 from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>2024
3Figure S2 from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>2024
4Figure S5 from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>2024
5Supplementary Methods from Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses <i>In Vivo</i>2024